If you currently have Alzheimer's disease, you may be eligible to take part in a clinical trial testing the safety and efficacy of an investigational drug to treat Alzheimer's disease.

Eligibility Requirements

Eligible participants must:

• Have a diagnosis of Alzheimer's disease
• Be between the ages of 60 and 85
• Have been taking a stable dose of donepezil (Aricept) for at least three months. 

Study Requirements

The duration of the study is approximately 7½ months with a total of 14 visits. All participants must also have a primary caregiver who is willing to accompany you to all visits and help supervise the study treatment at home.

Compensation

Study-related medical examinations, lab tests, investigational drug, and compensation for time and travel will be provided.

For more information, contact Mari Kopping at 919-668-0326.